Peptides that bind to the erythropoietin receptor
US7528104B2 · kind B2 · utility
7Cited by
59References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2004 |
| Grant date | May 5, 2009 |
| Priority date | — |
| Expiry date | Mar 19, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.